المؤلفون: Huang M; Department of Medical Sciences, Graduate School of Ajou University, Suwon, Republic of Korea., Park J; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea., Seo J; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea., Ko S; Department of Biomedical Sciences, Graduate School, Korea University, Seoul, Republic of Korea., Yang YH; Department of Biomedical Sciences, Graduate School of Ajou University, Suwon, Republic of Korea., Lee Y; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea., Kim HJ; Department of Otolaryngology, Ajou University School of Medicine, Suwon, Republic of Korea., Lee BS; Department of Otolaryngology, Ajou University School of Medicine, Suwon, Republic of Korea., Lee YS; Department of Otolaryngology, Ajou University School of Medicine, Suwon, Republic of Korea., Ko BJ; School of Biopharmaceutical and Medical Sciences, Sungshin Women's University, Seoul, Republic of Korea., Jung ST; Department of Biomedical Sciences, Graduate School, Korea University, Seoul, Republic of Korea.; Institute of Human Genetics, Korea University College of Medicine, Seoul, Republic of Korea.; BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea., Park D; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.; Advanced College of Bio-convergence Engineering, Ajou University, Suwon, Republic of Korea., Yoo TH; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.; Advanced College of Bio-convergence Engineering, Ajou University, Suwon, Republic of Korea., Kim CH; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.; Department of Biomedical Sciences, Graduate School of Ajou University, Suwon, Republic of Korea.; Department of Otolaryngology, Ajou University School of Medicine, Suwon, Republic of Korea.

المصدر: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Jul 15; Vol. 38 (13), pp. e23759.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE

مواضيع طبية MeSH: ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/metabolism , ErbB Receptors*/immunology , Immunotoxins*/pharmacology , Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/immunology , Head and Neck Neoplasms*/metabolism , Immunoglobulin G*/pharmacology , Virulence Factors* , Pseudomonas aeruginosa Exotoxin A* , Exotoxins*/pharmacology , ADP Ribose Transferases*, Humans ; Animals ; Mice ; Cell Line, Tumor ; Xenograft Model Antitumor Assays ; Cetuximab/pharmacology ; Mice, Nude ; Bacterial Toxins ; Apoptosis/drug effects ; Mice, Inbred BALB C ; Female ; Cell Movement/drug effects ; Antineoplastic Agents/pharmacology

المؤلفون: Patil BR; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Bhadane KV; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Ahmad I; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Agrawal YJ; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Shimpi AA; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Dhangar MS; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Patel HM; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India. Electronic address: hpatel_38@yahoo.com.

المصدر: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Jul 15; Vol. 109, pp. 117796. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3391 (Electronic) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Acrylamides*/chemistry , Acrylamides*/pharmacology , Aniline Compounds*/chemistry , Aniline Compounds*/pharmacology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/metabolism , ErbB Receptors*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Protein Kinase Inhibitors*/chemistry , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/chemical synthesis , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemical synthesis , Mutation*, Humans ; Structure-Activity Relationship ; Molecular Structure ; Piperazines/chemistry ; Piperazines/pharmacology ; Indoles ; Pyrimidines

المؤلفون: Ma S; Department of Chemistry, Jess and Mildred Fisher College of Science and Mathematics, Towson University, Towson, Maryland 21252, United States., Patel H; Department of Chemistry, Jess and Mildred Fisher College of Science and Mathematics, Towson University, Towson, Maryland 21252, United States., Peeples CA; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States., Shen J; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States.

المصدر: Journal of chemical theory and computation [J Chem Theory Comput] 2024 Jul 09; Vol. 20 (13), pp. 5528-5538. Date of Electronic Publication: 2024 Jun 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101232704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-9626 (Electronic) Linking ISSN: 15499618 NLM ISO Abbreviation: J Chem Theory Comput Subsets: MEDLINE

مواضيع طبية MeSH: ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/chemistry , ErbB Receptors*/metabolism , Afatinib*/chemistry , Afatinib*/pharmacology , Quantum Theory* , Molecular Dynamics Simulation*, Humans ; Protein Kinase Inhibitors/chemistry ; Protein Kinase Inhibitors/pharmacology ; Thermodynamics ; Structure-Activity Relationship ; Quinazolines/chemistry ; Quinazolines/pharmacology

المؤلفون: Mani L; Department of Otolaryngology, Vanderbilt University, Nashville, USA., Naveed A; Department of Otolaryngology, Vanderbilt University, Nashville, USA., McAdoo A; Department of Otolaryngology, Vanderbilt University, Nashville, USA., Rosenthal E; Department of Otolaryngology, Vanderbilt University, Nashville, USA., Hom M; Department of Otolaryngology, Vanderbilt University, Nashville, USA.

المصدر: Carcinogenesis [Carcinogenesis] 2024 Jul 08; Vol. 45 (7), pp. 520-526.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN: 1460-2180 (Electronic) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: MEDLINE

مواضيع طبية MeSH: Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/pathology , Head and Neck Neoplasms*/metabolism , Antibodies, Monoclonal, Humanized*/pharmacology , Xenograft Model Antitumor Assays* , ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/metabolism, Animals ; Humans ; Mice ; Cell Line, Tumor ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/pathology ; Female ; Mice, Nude ; Cell Proliferation/drug effects ; Immunoconjugates

المؤلفون: Álvarez-Vázquez A; Department of Biochemistry and Molecular Biology, Neuroscience Institute of Castilla y León (INCyL), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., San-Segundo L; Centre for Cancer Research-IBMCC (CSIC), IBSAL, Salamanca, Spain., Cerveró-García P; Department of Biochemistry and Molecular Biology, Neuroscience Institute of Castilla y León (INCyL), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Flores-Hernández R; Department of Biochemistry and Molecular Biology, Neuroscience Institute of Castilla y León (INCyL), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Ollauri-Ibáñez C; Department of Biochemistry and Molecular Biology, Neuroscience Institute of Castilla y León (INCyL), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Segura-Collar B; Instituto de investigaciones Biomédicas I+12 (Imas12), Hospital 12 de Octubre, Madrid, Spain., Hubert CG; Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio, USA., Morrison G; Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK., Pollard SM; Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK., Lathia JD; Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Sánchez-Gómez P; Neuro-Oncology Unit, Instituto de Salud Carlos III (ISCIII-UFIEC), Madrid, Spain., Tabernero A; Department of Biochemistry and Molecular Biology, Neuroscience Institute of Castilla y León (INCyL), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.

المصدر: Neuro-oncology [Neuro Oncol] 2024 Jul 05; Vol. 26 (7), pp. 1230-1246.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/drug therapy , Glioblastoma*/pathology , Glioblastoma*/metabolism , ErbB Receptors*/genetics , ErbB Receptors*/metabolism , Brain Neoplasms*/drug therapy , Brain Neoplasms*/pathology , Brain Neoplasms*/metabolism , Gene Amplification* , Temozolomide*/pharmacology , Xenograft Model Antitumor Assays*, Animals ; Humans ; Mice ; Erlotinib Hydrochloride/pharmacology ; Tumor Cells, Cultured ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/pathology ; Neoplastic Stem Cells/metabolism

المؤلفون: Yan J; IRSD - Institut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France.; Department of Gastroenterology, The Second Xiangya Hospital of Central South University, Changsha, China.; Research Center of Digestive Disease, Central South University, Changsha, China., Racaud-Sultan C; IRSD - Institut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France., Pezier T; ISP, INRAE, Université de Tours, 37380, Nouzilly, France., Edir A; IRSD - Institut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France., Rolland C; IRSD - Institut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France., Claverie C; IRSD - Institut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France., Burlaud-Gaillard J; Plateforme IBISA de Microscopie Electronique, Université de Tours, CHRU de Tours, Tours, France., Olivier M; ISP, INRAE, Université de Tours, 37380, Nouzilly, France., Velge P; ISP, INRAE, Université de Tours, 37380, Nouzilly, France., Lacroix-Lamandé S; ISP, INRAE, Université de Tours, 37380, Nouzilly, France., Vergnolle N; IRSD - Institut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France., Wiedemann A; IRSD - Institut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France. agnes.wiedemann@inrae.fr.; ISP, INRAE, Université de Tours, 37380, Nouzilly, France. agnes.wiedemann@inrae.fr.

المصدر: Scientific reports [Sci Rep] 2024 Jul 02; Vol. 14 (1), pp. 15160. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Organoids*/microbiology , Stem Cells*/metabolism , Salmonella typhimurium*/pathogenicity , Salmonella typhimurium*/physiology , Cell Differentiation* , Salmonella Infections*/microbiology , Salmonella Infections*/pathology , ErbB Receptors*/metabolism , ErbB Receptors*/genetics, Animals ; Mice ; Intestinal Mucosa/microbiology ; Intestinal Mucosa/pathology ; Cell Proliferation ; Disease Models, Animal ; Mice, Inbred C57BL

المؤلفون: Aye PS; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand., Barnes J; School of Pharmacy, University of Auckland, Auckland, New Zealand., Laking G; Te Aka Mātauranga Matepukupuku Centre for Cancer Research, University of Auckland, Auckland, New Zealand., Cameron L; Department of Medical Oncology, Te Pūriri o Te Ora Regional Cancer and Blood Service, Te Whatu Ora Health New Zealand, Auckland City Hospital, Auckland, New Zealand., Anderson M; Department of Medical Oncology, Te Whatu Ora Health New Zealand Te Pae Hauuora o Ruahine o Tararua, Palmerston North Hospital, Palmerston North, New Zealand., Luey B; Wellington Blood and Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast and Hutt Valley, Wellington Hospital, Wellington, New Zealand., Delany S; Department of Oncology, Te Whatu Ora Health New Zealand Nelson Marlborough, Nelson Hospital, Nelson, New Zealand., Harris D; Oncology Service, Te Whatu Ora - Waitaha Canterbury, Christchurch Hospital, Christchurch, New Zealand., McLaren B; Southern Blood and Cancer Service, Te Whatu Ora Southern, Dunedin Hospital, Dunedin, New Zealand., Brenman E; Cancer and Haematology Services, Te Whatu Ora Health New Zealand Haora a Toi Bay of Plenty, Tauranga Hospital, Tauranga, New Zealand., Wong J; Cancer Services, Te Whatu Ora Health New Zealand Waikato, Waikato Hospital, Hamilton, New Zealand., Lawrenson R; Medical Research Centre, University of Waikato, Hamilton, New Zealand., Arendse M; Department of Pathology, Te Whatu Ora Health New Zealand Waikato, Waikato Hospital, Hamilton, New Zealand., Tin Tin S; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand., Elwood M; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand., Hope P; Lung Foundation New Zealand, Manukau, Auckland, New Zealand., McKeage MJ; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand.; Department of Medical Oncology, Te Pūriri o Te Ora Regional Cancer and Blood Service, Te Whatu Ora Health New Zealand, Auckland City Hospital, Auckland, New Zealand.; Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.

المصدر: JMIR research protocols [JMIR Res Protoc] 2024 Jul 02; Vol. 13, pp. e51381. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE

مواضيع طبية MeSH: Erlotinib Hydrochloride*/therapeutic use , Erlotinib Hydrochloride*/adverse effects , Gefitinib*/therapeutic use , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Mutation*, Humans ; Retrospective Studies ; New Zealand ; Female ; Male ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/adverse effects ; Cohort Studies ; Middle Aged ; Aged

المؤلفون: Li Z; Department of Oncology and Hematology, Yan'an People's Hospital, Yan'an, China., Yu H; Department of Medical Oncology, Tongliao City Hospital, Tongliao, China., Hussain SA; Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia., Yang R; Department of Medical Oncology, Yan'an People's Hospital, Yan'an, China.

المصدر: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Jul; Vol. 38 (7), pp. e23763.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet ISSN: 1099-0461 (Electronic) Linking ISSN: 10956670 NLM ISO Abbreviation: J Biochem Mol Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: ErbB Receptors*/metabolism , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Apoptosis*/drug effects , Oxidative Stress*/drug effects , Xenograft Model Antitumor Assays*, Humans ; Animals ; A549 Cells ; Mice ; Mice, Nude ; Inflammation/drug therapy ; Inflammation/metabolism ; Inflammation/pathology ; Mice, Inbred BALB C ; Antineoplastic Agents/pharmacology ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/metabolism ; Cell Line, Tumor

المؤلفون: El Hamaky NFM; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt., Hamdi A; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: Abdelrahmanhamdi2012@mans.edu.eg., Bayoumi WA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt., Elgazar AA; Department of Pharmacognosy, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt., Nasr MNA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University, New Damietta 34518, Egypt.

المصدر: Bioorganic chemistry [Bioorg Chem] 2024 Jul; Vol. 148, pp. 107437. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/chemical synthesis , Molecular Docking Simulation* , Triazoles*/chemistry , Triazoles*/pharmacology , Triazoles*/chemical synthesis , Drug Screening Assays, Antitumor* , Drug Design* , Vascular Endothelial Growth Factor Receptor-2*/antagonists & inhibitors , Vascular Endothelial Growth Factor Receptor-2*/metabolism , ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/metabolism , Cell Proliferation*/drug effects , DNA Topoisomerases, Type II*/metabolism , Dose-Response Relationship, Drug*, Humans ; Structure-Activity Relationship ; Molecular Structure ; Quinazolines/pharmacology ; Quinazolines/chemistry ; Quinazolines/chemical synthesis ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/chemistry ; Protein Kinase Inhibitors/chemical synthesis ; Apoptosis/drug effects ; Cell Line, Tumor ; Topoisomerase II Inhibitors/pharmacology ; Topoisomerase II Inhibitors/chemistry ; Topoisomerase II Inhibitors/chemical synthesis

المؤلفون: Abdelkhalek AS; Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt., Kothayer H; Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt., Soltan MK; Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.; Pharmacy Program, Oman College of Health Sciences, Muscat, Sultanate of Oman., Ibrahim SM; Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt., Elbaramawi SS; Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.

المصدر: Archiv der Pharmazie [Arch Pharm (Weinheim)] 2024 Jul; Vol. 357 (7), pp. e2300627. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 0330167 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4184 (Electronic) Linking ISSN: 03656233 NLM ISO Abbreviation: Arch Pharm (Weinheim) Subsets: MEDLINE

مواضيع طبية MeSH: ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/metabolism , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemical synthesis , Antineoplastic Agents*/chemistry , Apoptosis*/drug effects , Quinazolines*/pharmacology , Quinazolines*/chemistry , Quinazolines*/chemical synthesis , Drug Design* , Cell Proliferation*/drug effects , Triazoles*/pharmacology , Triazoles*/chemistry , Triazoles*/chemical synthesis , Drug Screening Assays, Antitumor* , Molecular Docking Simulation* , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/chemical synthesis , Protein Kinase Inhibitors*/chemistry, Humans ; Structure-Activity Relationship ; Cell Line, Tumor ; Molecular Structure ; Dose-Response Relationship, Drug ; Chalcones/pharmacology ; Chalcones/chemical synthesis ; Chalcones/chemistry ; HCT116 Cells ; Acetamides/pharmacology ; Acetamides/chemistry ; Acetamides/chemical synthesis ; MCF-7 Cells ; Chalcone/pharmacology ; Chalcone/chemistry ; Chalcone/chemical synthesis